. Author manuscript; available in PMC: 2015 Sep 1.

Published in final edited form as: Cancer Prev Res (Phila). 2014 Jun 3;7(9):950–957. doi: 10.1158/1940-6207.CAPR-14-0075

Table 3. Effect of polymorphisms rs11781886 and rs2228013 on total, low grade, and high grade prostate cancer risk in all participants of SELECT case-control cohort.

Polymorphism	Hazard Ratio	95% HR Confidence Limits	p value
Total Prostate Cancer
rs11781886	1.072	0.967-1.188	0.1852
rs2228013	0.953	0.759-1.196	0.6773
Low grade
rs11781886	1.076	0.951-1.218	0.2463
rs2228013	1.008	0.771-1.318	0.9529
High grade
rs11781886	1.099	0.939-1.286	0.2390
rs2228013	0.933	0.654-1.329	0.6994